Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other analysts have also issued reports on ALLO. Oppenheimer initiated coverage on shares of Allogene Therapeutics in a research note on Thursday, August 8th. […]
More Stories
Brokerages Set Centene Corporation (NYSE:CNC) PT at $49.94
Shares of Centene Corporation (NYSE:CNC – Get Free Report) have earned a consensus recommendation of “Hold” from the eighteen ratings...
Baker Avenue Asset Management LP Lowers Stake in Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)
Baker Avenue Asset Management LP lowered its stake in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report)...
Glassman Wealth Services Acquires 11,692 Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)
Glassman Wealth Services grew its holdings in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by 198.3%...
Vanguard Information Technology ETF (NYSEARCA:VGT) Shares Bought by Altiora Financial Group LLC
Altiora Financial Group LLC grew its position in Vanguard Information Technology ETF (NYSEARCA:VGT – Free Report) by 7.9% in the...
Baker Avenue Asset Management LP Increases Stock Holdings in iShares Russell 1000 Growth ETF (NYSEARCA:IWF)
Baker Avenue Asset Management LP raised its stake in iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 0.0%...
Heritage Wealth Advisors Trims Position in iShares Core MSCI EAFE ETF (BATS:IEFA)
Heritage Wealth Advisors trimmed its stake in shares of iShares Core MSCI EAFE ETF (BATS:IEFA – Free Report) by 0.4%...